Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma

OBJECTIVES: The Intergroup 0116 study has demonstrated a significant survival benefit for completely resected (R0) gastric cancer patients treated with a fluorouracil/leucovorin chemoradiotherapy regimen. However, this regimen is also toxic and less effective in terms of distant disease control. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yong, Zhao, Guoqi, Xu, Yi, Zhang, Tiening, Chen, Zhixiao, Yan, Ge, Tu, Wenzhi, Hu, Ye, Chen, Ying, He, Xia, Li, Xiaodong, Chen, Hui, Yao, Shengyu, Hu, Zhekai, Chen, Xuming, Chen, Tingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Articles: Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023597/
https://www.ncbi.nlm.nih.gov/pubmed/28263232
http://dx.doi.org/10.1097/COC.0000000000000373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023597/
https://www.ncbi.nlm.nih.gov/pubmed/28263232
http://dx.doi.org/10.1097/COC.0000000000000373

Ejemplares similares